Chloroquine Supplier-Buyer Network — Trade Flow Analysis

Name: Chloroquine Supplier-Buyer Trade Network Dataset — 287+ Indian Exporters, 14+ Importers, 120+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Chloroquine supplier network, Chloroquine buyers, pharmaceutical export India, Chloroquine trade data

TransData Nexus

Chloroquine

India Pharmaceutical Trade Intelligence

$171.3M287 Suppliers120 CountriesHS 30049099

ExportsIndia → UNITED STATES74.0%India → PHILIPPINES9.0%

ImportsUNITED STATES → India$9.3K THAILAND → India$1.5K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Who Supplies Chloroquine? Top Manufacturers & Buyers 2026 — ZYDUS LIFESCIENCES LIMITED Leads | TransData Nexus | TransData Nexus

1ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the first-largest Chloroquine exporter from India, with a market share of 64.7% and a total export value of $110.7M across 260 shipments. Their average shipment value of $425.9K is above the market average of $31.5K, suggesting premium or bulk contract pricing.

ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES,LLC is the dominant customer, accounting for 94.4% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCES SERVICES,LLC — $104.6M across 246 shipments (94.4% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $4.4M across 10 shipments (3.9% of this supplier's total exports)

• EVERSANA LIFE SCIENCES SERVICES,LLC — $638.2K across 1 shipments (0.6% of this supplier's total exports)

• SARL CPCM — $612.4K across 1 shipments (0.6% of this supplier's total exports)

• PRIORITY HEALTHCARE DISTRIBUTION — $537.1K across 1 shipments (0.5% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $425.9K is 1252% above the market average of $31.5K, consistent with large-order contracts or value-added formulations.

2IPCA LABORATORIES LIMITED

IPCA LABORATORIES LIMITED is the second-largest Chloroquine exporter from India, with a market share of 13.2% and a total export value of $22.6M across 382 shipments. Their average shipment value of $59.2K is above the market average of $31.5K, suggesting premium or bulk contract pricing.

IPCA LABORATORIES LIMITED serves 5 named buyers in our database. BLUE GLOBAL (FZE) is the dominant customer, accounting for 63.4% of this supplier's tracked business. Top customers include:

• BLUE GLOBAL (FZE) — $14.4M across 242 shipments (63.4% of this supplier's total exports)

• NA — $3.2M across 54 shipments (14.1% of this supplier's total exports)

• MEDICAL INTERNATIONA — $2.0M across 34 shipments (8.9% of this supplier's total exports)

• IPCA LABORATORIES UK LIMITED — $1.7M across 28 shipments (7.4% of this supplier's total exports)

• IPCA LABORATORIES LIMITED SUC. COLO — $1.4M across 23 shipments (6.1% of this supplier's total exports)

Key Insight: IPCA LABORATORIES LIMITED's per-shipment value of $59.2K is 88% above the market average of $31.5K, consistent with large-order contracts or value-added formulations.

3CADILA HEALTHCARE LIMITED

CADILA HEALTHCARE LIMITED is the third-largest Chloroquine exporter from India, with a market share of 3.7% and a total export value of $6.3M across 41 shipments. Their average shipment value of $153.8K is above the market average of $31.5K, suggesting premium or bulk contract pricing.

CADILA HEALTHCARE LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES,LLC is the dominant customer, accounting for 84.6% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCES SERVICES,LLC — $5.3M across 35 shipments (84.6% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $280.9K across 2 shipments (4.5% of this supplier's total exports)

• PRIORITY HEALTHCARE DISTRIBUTION — $277.5K across 2 shipments (4.4% of this supplier's total exports)

• KASPA PHARMACEUTICAL — $208.0K across 1 shipments (3.3% of this supplier's total exports)

• HAPHARCO J S C BRANC — $205.7K across 1 shipments (3.3% of this supplier's total exports)

Key Insight: CADILA HEALTHCARE LIMITED's per-shipment value of $153.8K is 388% above the market average of $31.5K, consistent with large-order contracts or value-added formulations.

4CADILA HEALTHCARE LTD

CADILA HEALTHCARE LTD is the fourth-largest Chloroquine exporter from India, with a market share of 1.6% and a total export value of $2.8M across 14 shipments. Their average shipment value of $196.7K is above the market average of $31.5K, suggesting premium or bulk contract pricing.

CADILA HEALTHCARE LTD serves 4 named buyers in our database. EVERSANA LIFE SCIENCES SERVICES,LLC is the dominant customer, accounting for 76.7% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCES SERVICES,LLC — $2.1M across 11 shipments (76.7% of this supplier's total exports)

• HAPHARCO J S C BRANC — $518.6K across 3 shipments (18.8% of this supplier's total exports)

• KASPA PHARMACEUTICAL — $88.6K across 0 shipments (3.2% of this supplier's total exports)

• SUNSHINE HEALTHCARE — $35.5K across 0 shipments (1.3% of this supplier's total exports)

Key Insight: CADILA HEALTHCARE LTD's per-shipment value of $196.7K is 525% above the market average of $31.5K, consistent with large-order contracts or value-added formulations.

5INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the fifth-largest Chloroquine exporter from India, with a market share of 0.5% and a total export value of $898.4K across 21 shipments. Their average shipment value of $42.8K is above the market average of $31.5K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EVERSANA LIFE SCIENCES SERVICES,LLC — $369.3K across 9 shipments (41.1% of this supplier's total exports)

• EVERSANA LIFE SCIENCES SERVICES,LLC — $368.9K across 9 shipments (41.1% of this supplier's total exports)

• TO THE ORDER — $143.6K across 3 shipments (16.0% of this supplier's total exports)

• NORA PHARMA INC — $16.6K across 0 shipments (1.8% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $42.8K is 36% above the market average of $31.5K, consistent with large-order contracts or value-added formulations.

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Chloroquine exporter from India, with a market share of 0.2% and a total export value of $423.1K across 14 shipments. Their average shipment value of $30.2K is below the market average of $31.5K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• RANBAXY (THAILAND) CO., LTD. — $172.0K across 6 shipments (40.7% of this supplier's total exports)

• RANBAXY THAILAND CO — $152.7K across 5 shipments (36.1% of this supplier's total exports)

• RANBAXY (THAILAND) CO., LTD. — $59.6K across 2 shipments (14.1% of this supplier's total exports)

• RANBAXY (THAILAND) CO., LTD. — $38.8K across 1 shipments (9.2% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (14 shipments) at a per-shipment value of $30.2K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Chloroquine imports from India, with a total trade value of $126.8M across 281 shipments — representing a 74.0% share of all Chloroquine exports. The average shipment value of $451.3K is above the global average of $31.5K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Chloroquine importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 90.2% ($114.4M) of this market's total imports.

• EVERSANA LIFE SCIENCE SERVICES — $114.4M (90.2% of United States's total)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $4.4M (3.4% of United States's total)

• EVERSANA LIFE SCIENCE SERVICES, — $1.3M (1.0% of United States's total)

Key Insight: United States's per-shipment average of $451.3K (1333% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Chloroquine imports from India.

Primary Market

Secondary Market

2Philippines

Philippines ranks as the second-largest destination for Chloroquine imports from India, with a total trade value of $15.4M across 21 shipments — representing a 9.0% share of all Chloroquine exports. The average shipment value of $734.4K is above the global average of $31.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Chloroquine importers in Philippines: BLUE GLOBAL (FZE) is the largest buyer, accounting for 94.0% ($14.5M) of this market's total imports.

• BLUE GLOBAL (FZE) — $14.5M (94.0% of Philippines's total)

Key Insight: Philippines's per-shipment average of $734.4K (2231% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Chloroquine imports from India.

Primary Market

Secondary Market

3Thailand

Thailand ranks as the third-largest destination for Chloroquine imports from India, with a total trade value of $2.7M across 8 shipments — representing a 1.6% share of all Chloroquine exports. The average shipment value of $337.8K is above the global average of $31.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Chloroquine importers in Thailand: RANBAXY (THAILAND) CO., LTD. is the largest buyer, accounting for 35.5% ($960.2K) of this market's total imports.

• RANBAXY (THAILAND) CO., LTD. — $960.2K (35.5% of Thailand's total)

Key Insight: Thailand's per-shipment average of $337.8K (973% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Chloroquine imports from India.

Primary Market

Secondary Market

4United Kingdom

United Kingdom ranks as the fourth-largest destination for Chloroquine imports from India, with a total trade value of $2.6M across 55 shipments — representing a 1.5% share of all Chloroquine exports. The average shipment value of $48.1K is above the global average of $31.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Chloroquine importers in United Kingdom: IPCA LABORATORIES UK LIMITED is the largest buyer, accounting for 99.8% ($2.6M) of this market's total imports.

• IPCA LABORATORIES UK LIMITED — $2.6M (99.8% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $48.1K (53% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Chloroquine imports from India.

Primary Market

Secondary Market

5Nigeria

Nigeria ranks as the fifth-largest destination for Chloroquine imports from India, with a total trade value of $2.4M across 45 shipments — representing a 1.4% share of all Chloroquine exports. The average shipment value of $54.4K is above the global average of $31.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Chloroquine importers in Nigeria: EMBASSY PHARMACEUTICAL AND is the largest buyer, accounting for 21.0% ($514.5K) of this market's total imports.

• EMBASSY PHARMACEUTICAL AND — $514.5K (21.0% of Nigeria's total)

Key Insight: Nigeria's per-shipment average of $54.4K (73% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Nigeria is a key market for Chloroquine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Chloroquine.
2.Flow Mapping: 287 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 5,437 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 120 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

5,437 Verified Shipments

287 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Chloroquine

Chloroquine

Who Supplies Chloroquine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Chloroquine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Chloroquine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ZYDUS LIFESCIENCES LIMITED

2IPCA LABORATORIES LIMITED

3CADILA HEALTHCARE LIMITED

4CADILA HEALTHCARE LTD

5INTAS PHARMACEUTICALS LIMITED

6SUN PHARMACEUTICAL INDUSTRIES LIMITED

From Indian Factories to Global Pharmacies — How Chloroquine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Chloroquine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Philippines

3Thailand

4United Kingdom

5Nigeria

People Also Ask — Chloroquine Supplier & Trade Network

Chloroquine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology